FindTrial
Sign In

Cardiac Involvement of Coronavirus Disease 2019 Assessed by Cardiac Magnetic Resonance: A Meta-analysis

Cardiac Involvement of Coronavirus Disease 2019 Assessed by Cardiac Magnetic Resonance: A Meta-analysis - Cardiac Involvement by COVID-19: A meta-analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000044237
Enrollment
Unknown
Registered
2021-05-17
Start date
2021-05-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Sponsors

Department of Diagnostic Radiology, Yokohama City University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: In the electronic search, we will systematically searched Pubmed, EMBASE, the Cochrane Central Register of Controlled Trials, and Web of Science Core Collection. Search formulas were presented as supplementary data.

Exclusion criteria

Exclusion criteria: Case report will be excluded from analysis.

Design outcomes

Primary

MeasureTime frame
Prevalence of cardiac involvement in patients with COVID-19 (LV or RV dysfunction, myocardial edema (T2WI, T2 mapping), non-ischemic myocardial injury (LGE, native T1 mapping)).—

Countries

Japan

Contacts

Public ContactShingo Kato

Yokohama City University Graduate School of Medicine Department of Diagnostic Radiology

sk513@yokohama-cu.ac.jp045-787-2696

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026